home / stock / tars / tars news

TARS News and Press, Tarsus Pharmaceuticals Inc. From 05/06/22

Stock Information
Company Name: Tarsus Pharmaceuticals Inc.
Stock Symbol: TARS
Market: NASDAQ
Website: tarsusrx.com
Menu
TARS TARS Quote TARS Short TARS News TARS Articles TARS Message Board
Get TARS Alerts

News, Short Squeeze, Breakout and More Instantly...
TARS - Tarsus to Present at Bank of America 2022 Healthcare Conference

IRVINE, Calif., May 06, 2022 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced that Bobak Azamian, M.D., Ph.D....
TARS - Tarsus Presents New Findings from Two Studies Demonstrating the Impact of Demodex Blepharitis at the ARVO 2022 Annual Meeting

IRVINE, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, presented data from its Atlas Continuation stud...

TARS - Tarsus Pharmaceuticals prices upsized $75.6M stock offering

Tarsus Pharmaceuticals (NASDAQ:TARS) priced its upsized underwritten public offering of 5.6M shares at a public offering price of $13.50/share, representing $75.6M of stock. Underwriters granted 30-day option to purchase up to 840K additional shares. Offer is expected to close on or abou...

TARS - MFGP, API and AQST among pre market gainers

Sonoma Pharmaceuticals SNOA +47% on EPA approval of Nanocyn as hospital-grade disinfectant. Field Trip Health (FTRP) +23%. Harbor Custom Development (HCDI) +18%. Western Digital WDC +12% as activist Elliott calls for separation of flash business. AST SpaceMobile ASTS ...
TARS - Tarsus Announces Pricing of Upsized $75.6 Million Underwritten Public Offering of Common Stock

IRVINE, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) (the “Company” or “Tarsus”), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with e...

TARS - Tarsus Pharmaceuticals closes down 23% following $50M public stock offering

Tarsus Pharmaceuticals (NASDAQ:TARS) closed down more than 23% Monday after the company said it would raise $50M in a stock offering earlier in the day. On Monday, Tarsus (TARS) also announced positive top-line data from a second phase 3 trial of TP-03 (lotilaner ophthalmic solution...

TARS - ACCD, AFI and SEER among mid-day movers

Gainers: Redbox Entertainment (RDBX) +48%. Blue Apron Holdings (APRN) +36%. Accolade (ACCD) +28%. Forge Global Holdings (FRGE) +22%. Hilltop Holdings (HTH) +19%. The Oncology Institute (TOI) +18%. OppFi (OPFI) +18%. Seer (SEER) +16%. Companhia Energetica de Minas Gerais (CIG) +16%. Silk Road ...
TARS - Silk Road Medical, Clene top healthcare gainers; Global Cord Blood, Zosano lead losers' pack

Gainers: Silk Road Medical (SILK) +12%. Clene (CLNN) +6%. BioCardia (BCDA) +2%. Veru (VERU) +2%. ERYTECH Pharma (ERYP) +1%. Losers: Global Cord Blood (CO) -28%. Zosano Pharma (ZSAN) -21%. Vaxxinity (VAXX) -17%. HUTCHMED (China) (HCM)...

TARS - Tarsus Pharmaceuticals to raise $50M in stock offering

Tarsus Pharmaceuticals (NASDAQ:TARS) commenced an underwritten public offering of $50M of shares; underwriters granted 30-day option to purchase an additional 15% of the shares. Offer size, terms yet to be decided. For further details see: Tarsus Pharmaceuticals to raise $50M ...

TARS - Tarsus Announces Proposed $50 Million Underwritten Public Offering of Shares of its Common Stock

IRVINE, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) (the “Company” or “Tarsus”), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with e...
Previous 10 Next 10